(MBLY) Mobileye Global Common Stock - Ratings and Ratios
Camera, Chipset, Cloud, Fleet, Pilot
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 62.6% |
| Value at Risk 5%th | 96.9% |
| Relative Tail Risk | -5.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.58 |
| Alpha | -65.85 |
| CAGR/Max DD | -0.43 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 1.757 |
| Beta Downside | 1.539 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.63% |
| Mean DD | 46.05% |
| Median DD | 49.25% |
Description: MBLY Mobileye Global Common Stock January 03, 2026
Mobileye Global Inc. (NASDAQ: MBLY) designs, manufactures and sells advanced driver-assistance systems (ADAS) and full-stack autonomous-driving solutions for OEMs, automotive suppliers and fleet operators. Its product hierarchy ranges from Base ADAS (front-camera safety features) through Cloud-Enhanced and Surround ADAS (hands-off highway functions) to end-to-end platforms such as SuperVision, Mobileye Chauffeur and Mobileye Drive, all powered by the proprietary EyeQ system-on-chip and the True Redundancy AI architecture.
In FY 2023 the company reported roughly $1.5 billion of revenue-a 30 % year-over-year increase-driven by expanding shipments of EyeQ chips (≈10 million units) and new contracts with Tier-1 suppliers for robotaxi deployments. The ADAS market is projected to reach $90 billion by 2027, fueled by tightening safety regulations (e.g., EU mandatory lane-keeping assist) and the broader electrification-autonomy convergence that raises vehicle software spend as a larger share of total cost of ownership.
For a deeper dive into Mobileye’s valuation multiples, growth assumptions and competitive positioning, you may find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (-336.0m TTM) > 0 and > 6% of Revenue (6% = 116.3m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 3.33pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 105.4% (prev 96.45%; Δ 8.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 693.0m > Net Income -336.0m (YES >=105%, WARN >=100%) |
| Net Debt (-1.75b) to EBITDA (176.0m) ratio: -9.94 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.46 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (800.0m) change vs 12m ago -1.36% (target <= -2.0% for YES) |
| Gross Margin 48.66% (prev 46.86%; Δ 1.80pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 15.45% (prev 14.29%; Δ 1.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -18.78 (EBITDA TTM 176.0m / Interest Expense TTM -18.0m) >= 6 (WARN >= 3) |
Altman Z'' -6.34
| (A) 0.16 = (Total Current Assets 2.42b - Total Current Liabilities 374.0m) / Total Assets 12.48b |
| (B) -0.27 = Retained Earnings (Balance) -3.33b / Total Assets 12.48b |
| (C) -0.03 = EBIT TTM -338.0m / Avg Total Assets 12.54b |
| (D) -6.06 = Book Value of Equity -3.31b / Total Liabilities 545.0m |
| Total Rating: -6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.77
| 1. Piotroski 4.50pt |
| 2. FCF Yield 8.16% |
| 3. FCF Margin 32.40% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -9.94 |
| 6. ROIC - WACC (= -14.61)% |
| 7. RoE -2.79% |
| 8. Rev. Trend 17.67% |
| 9. EPS Trend -53.34% |
What is the price of MBLY shares?
Over the past week, the price has changed by -9.09%, over one month by +1.06%, over three months by -27.59% and over the past year by -36.40%.
Is MBLY a buy, sell or hold?
- Strong Buy: 12
- Buy: 2
- Hold: 13
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the MBLY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 19.1 | 81.7% |
| Analysts Target Price | 19.1 | 81.7% |
| ValueRay Target Price | 8.9 | -15.1% |
MBLY Fundamental Data Overview January 13, 2026
P/S = 4.8499
P/B = 0.7875
P/EG = 0.4567
Revenue TTM = 1.94b USD
EBIT TTM = -338.0m USD
EBITDA TTM = 176.0m USD
Long Term Debt = unknown (none)
Short Term Debt = 13.0m USD (from shortTermDebt, last fiscal year)
Debt = 50.0m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.75b USD (from netDebt column, last quarter)
Enterprise Value = 7.70b USD (9.40b + Debt 50.0m - CCE 1.75b)
Interest Coverage Ratio = -18.78 (Ebit TTM -338.0m / Interest Expense TTM -18.0m)
EV/FCF = 12.26x (Enterprise Value 7.70b / FCF TTM 628.0m)
FCF Yield = 8.16% (FCF TTM 628.0m / Enterprise Value 7.70b)
FCF Margin = 32.40% (FCF TTM 628.0m / Revenue TTM 1.94b)
Net Margin = -17.34% (Net Income TTM -336.0m / Revenue TTM 1.94b)
Gross Margin = 48.66% ((Revenue TTM 1.94b - Cost of Revenue TTM 995.0m) / Revenue TTM)
Gross Margin QoQ = 48.21% (prev 49.80%)
Tobins Q-Ratio = 0.62 (Enterprise Value 7.70b / Total Assets 12.48b)
Interest Expense / Debt = 16.0% (Interest Expense 8.00m / Debt 50.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = -267.0m (EBIT -338.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.46 (Total Current Assets 2.42b / Total Current Liabilities 374.0m)
Debt / Equity = 0.00 (Debt 50.0m / totalStockholderEquity, last quarter 11.94b)
Debt / EBITDA = -9.94 (Net Debt -1.75b / EBITDA 176.0m)
Debt / FCF = -2.79 (Net Debt -1.75b / FCF TTM 628.0m)
Total Stockholder Equity = 12.03b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.68% (Net Income -336.0m / Total Assets 12.48b)
RoE = -2.79% (Net Income TTM -336.0m / Total Stockholder Equity 12.03b)
RoCE = -2.79% (EBIT -338.0m / Capital Employed (Total Assets 12.48b - Current Liab 374.0m))
RoIC = -2.22% (negative operating profit) (NOPAT -267.0m / Invested Capital 12.03b)
WACC = 12.39% (E(9.40b)/V(9.45b) * Re(12.39%) + D(50.0m)/V(9.45b) * Rd(16.0%) * (1-Tc(0.21)))
Discount Rate = 12.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF Debug] Terminal Value 63.25% ; FCFF base≈462.4m ; Y1≈451.8m ; Y5≈456.7m
Fair Price DCF = 28.31 (EV 4.37b - Net Debt -1.75b = Equity 6.11b / Shares 216.0m; r=12.39% [WACC]; 5y FCF grow -3.30% → 2.90% )
EPS Correlation: -53.34 | EPS CAGR: -27.21% | SUE: -4.0 | # QB: 0
Revenue Correlation: 17.67 | Revenue CAGR: 9.71% | SUE: 0.64 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=+0.003 | Revisions Net=-2 | Analysts=13
EPS next Year (2026-12-31): EPS=0.40 | Chg30d=-0.006 | Revisions Net=-1 | Growth EPS=+13.0% | Growth Revenue=+7.5%
Additional Sources for MBLY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle